JP2012528110A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012528110A5 JP2012528110A5 JP2012512352A JP2012512352A JP2012528110A5 JP 2012528110 A5 JP2012528110 A5 JP 2012528110A5 JP 2012512352 A JP2012512352 A JP 2012512352A JP 2012512352 A JP2012512352 A JP 2012512352A JP 2012528110 A5 JP2012528110 A5 JP 2012528110A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- binding protein
- sequence number
- antigen
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18183309P | 2009-05-28 | 2009-05-28 | |
| US61/181,833 | 2009-05-28 | ||
| US28893009P | 2009-12-22 | 2009-12-22 | |
| US61/288,930 | 2009-12-22 | ||
| PCT/EP2010/057228 WO2010136481A1 (en) | 2009-05-28 | 2010-05-26 | Il-13 binding protein |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012528110A JP2012528110A (ja) | 2012-11-12 |
| JP2012528110A5 true JP2012528110A5 (enExample) | 2013-07-11 |
| JP5919188B2 JP5919188B2 (ja) | 2016-05-18 |
Family
ID=42335086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012512352A Expired - Fee Related JP5919188B2 (ja) | 2009-05-28 | 2010-05-26 | Ｉｌ−１３結合タンパク質 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US8680245B2 (enExample) |
| EP (1) | EP2435481A1 (enExample) |
| JP (1) | JP5919188B2 (enExample) |
| KR (1) | KR20120034679A (enExample) |
| CN (1) | CN102459341A (enExample) |
| AR (1) | AR078047A1 (enExample) |
| AU (1) | AU2010251955A1 (enExample) |
| BR (1) | BRPI1016061A2 (enExample) |
| CA (1) | CA2763443A1 (enExample) |
| CO (1) | CO6400150A2 (enExample) |
| CR (1) | CR20110664A (enExample) |
| DO (1) | DOP2011000347A (enExample) |
| EA (1) | EA201190275A1 (enExample) |
| IL (1) | IL216261A0 (enExample) |
| MA (1) | MA33381B1 (enExample) |
| MX (1) | MX2011012622A (enExample) |
| PE (1) | PE20120401A1 (enExample) |
| SG (1) | SG176203A1 (enExample) |
| TW (1) | TW201107345A (enExample) |
| UY (1) | UY32664A (enExample) |
| WO (1) | WO2010136481A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
| ATE509033T1 (de) | 2006-03-20 | 2011-05-15 | Univ California | Manipulierte anti-prostatastammzellenantigen (psca)-antikörper für krebs-targeting |
| US8940298B2 (en) | 2007-09-04 | 2015-01-27 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection |
| JP5906090B2 (ja) | 2009-02-17 | 2016-04-20 | コーネル・リサーチ・ファンデーション・インコーポレイテッドＣｏｒｎｅｌｌ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ， Ｉｎｃｏｒｐｏｒａｔｅｄ | 癌の診断のための方法およびキットならびに治療価の推定 |
| PE20120401A1 (es) | 2009-05-28 | 2012-05-04 | Glaxo Group Ltd | Proteina de enlace de il-13 |
| CA3040276A1 (en) | 2009-12-02 | 2011-06-09 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
| CA3215087A1 (en) * | 2013-01-03 | 2014-07-10 | Meso Scale Technologies, Llc | Assay panels |
| EP2981286A4 (en) * | 2013-04-05 | 2016-08-24 | Hoffmann La Roche | ANTI-IL-4 ANTIBODIES AND BISPECIFIC ANTIBODIES AND USES THEREOF |
| IL318433A (en) | 2014-05-16 | 2025-03-01 | Ablynx Nv | Improved immunoglobulin variable complexes |
| LT3248986T (lt) * | 2014-05-16 | 2022-03-25 | Ablynx Nv | Imunoglobulino kintami domenai |
| WO2015200905A2 (en) * | 2014-06-28 | 2015-12-30 | Oligasis, Llc | Dual pdgf/vegf antagonists |
| WO2016054114A1 (en) * | 2014-09-29 | 2016-04-07 | The Regents Of The University Of California | Compositions for expanding regulatory t cells (treg), and treating autoimmune and inflammatory diseases and conditions |
| CN108136012B (zh) | 2015-08-07 | 2022-10-04 | 伊麦吉纳博公司 | 靶向分子的抗原结合构建体 |
| JP7044700B2 (ja) * | 2015-10-02 | 2022-03-30 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | 二重特異性抗ｃｅａｘｃｄ３ ｔ細胞活性化抗原結合分子 |
| WO2017189805A1 (en) | 2016-04-27 | 2017-11-02 | Abbvie Inc. | Methods of treatment of diseases in which il-13 activity is detrimental using anti-il-13 antibodies |
| WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
| TW202228789A (zh) * | 2020-10-15 | 2022-08-01 | 美商建南德克公司 | 用於長效遞送治療劑之多能蛋白聚醣（ｖｇ１）的玻尿酸結合衍生物 |
| CN118005784A (zh) * | 2022-11-08 | 2024-05-10 | 上海洛启生物医药技术有限公司 | 抗il-13长效纳米抗体序列及其应用 |
| WO2026114819A1 (en) * | 2024-11-26 | 2026-06-04 | Glaxosmithkline Intellectual Property Development Limited | Il-13 antigen binding proteins |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5859205A (en) * | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US7553487B2 (en) | 1998-12-14 | 2009-06-30 | Genetics Institute, Llc | Method and compositions for treating asthma |
| WO2003092610A2 (en) | 2002-05-01 | 2003-11-13 | Regeneron Pharmaceuticals, Inc. | Methods of using cytokine antagonists to treat hiv infection and aids |
| GB0414799D0 (en) * | 2004-07-01 | 2004-08-04 | Glaxo Group Ltd | Immunoglobulins |
| TWI307630B (en) | 2004-07-01 | 2009-03-21 | Glaxo Group Ltd | Immunoglobulins |
| GB0600488D0 (en) | 2006-01-11 | 2006-02-22 | Glaxo Group Ltd | Immunoglobulins |
| US20100047171A1 (en) | 2006-01-24 | 2010-02-25 | Roland Beckmann | Fusion Proteins That Contain Natural Junctions |
| BRPI0710572A2 (pt) * | 2006-01-24 | 2013-01-08 | Domantis Limited | ligante, uso do ligante, mÉtodos para o tratamento de uma doenÇa alÉrgica, de asma e de cÂncer, para a inibiÇço de uma resposta imune do tipo th2, e administraÇço de tratamento anti-il-4 e tratamento anti-il-13, composiÇço farmacÊutica, dispositivo de dispensaÇço de droga, Ácido nucleico isolado ou recombinante, vetor, cÉlula hospedeira, mÉtodos para a produÇço de um ligante e de inibiÇço da proliferaÇço de cÉlulas |
| TW200944231A (en) | 2007-11-30 | 2009-11-01 | Glaxo Group Ltd | Antigen-binding constructs |
| NZ601815A (en) | 2008-03-31 | 2014-10-31 | Genentech Inc | Compositions and methods for treating and diagnosing asthma |
| PE20120401A1 (es) | 2009-05-28 | 2012-05-04 | Glaxo Group Ltd | Proteina de enlace de il-13 |
-
2010
- 2010-05-26 PE PE2011002022A patent/PE20120401A1/es not_active Application Discontinuation
- 2010-05-26 BR BRPI1016061A patent/BRPI1016061A2/pt not_active IP Right Cessation
- 2010-05-26 AU AU2010251955A patent/AU2010251955A1/en not_active Abandoned
- 2010-05-26 EA EA201190275A patent/EA201190275A1/ru unknown
- 2010-05-26 MX MX2011012622A patent/MX2011012622A/es not_active Application Discontinuation
- 2010-05-26 US US13/321,982 patent/US8680245B2/en not_active Expired - Fee Related
- 2010-05-26 UY UY0001032664A patent/UY32664A/es unknown
- 2010-05-26 EP EP10722076A patent/EP2435481A1/en not_active Withdrawn
- 2010-05-26 CA CA2763443A patent/CA2763443A1/en not_active Abandoned
- 2010-05-26 MA MA34479A patent/MA33381B1/fr unknown
- 2010-05-26 KR KR1020117031392A patent/KR20120034679A/ko not_active Withdrawn
- 2010-05-26 US US12/787,588 patent/US20100303821A1/en not_active Abandoned
- 2010-05-26 SG SG2011086410A patent/SG176203A1/en unknown
- 2010-05-26 CN CN2010800337231A patent/CN102459341A/zh active Pending
- 2010-05-26 WO PCT/EP2010/057228 patent/WO2010136481A1/en not_active Ceased
- 2010-05-26 AR ARP100101814A patent/AR078047A1/es not_active Application Discontinuation
- 2010-05-26 JP JP2012512352A patent/JP5919188B2/ja not_active Expired - Fee Related
- 2010-05-26 TW TW099116859A patent/TW201107345A/zh unknown
-
2011
- 2011-11-10 IL IL216261A patent/IL216261A0/en unknown
- 2011-11-11 DO DO2011000347A patent/DOP2011000347A/es unknown
- 2011-11-25 CO CO11162427A patent/CO6400150A2/es not_active Application Discontinuation
- 2011-12-09 CR CR20110664A patent/CR20110664A/es unknown